Business Insider3y
A new kind of biotech is aiming to undercut Big Pharma with cheaper drugs. But skeptics question whether EQRx is just hype.
EQRx is the 13th biotech Borisy has helped launch, a list that includes high-profile companies like Foundation, the $2.9 billion protein specialist Relay Therapeutics, and the $5.4 billion ...
pharmaphorum12d
EQRx's low-price drugs mission ends with Revolution buy
EQRx's pledge to disrupt the pharma pricing system started with a clarion call in 2020 but ended with a whimper today with an agreement to be taken over by Revolution Medicines. Revolution and ...
pharmaphorum1y
New VC Curie.bio makes its debut with $500m+ war chest
Alexis Borisy, a former partner at Third Rock Ventures is serving as chair and will bring experience as a co-founder of a string of biotechs, including EQRX, Relay Therapeutics, and Blueprint ...